Why choose STD PCR
Most online testing brands are marketing companies that ship your specimen elsewhere. We are a physician-led molecular laboratory that runs your PCR test in-house, protects your privacy by design, and stays with you after the result.
Four differences you can actually verify
PCR, not antigen guesswork
Nucleic Acid Amplification Testing amplifies bacterial and viral DNA/RNA directly, so early-stage infections are detected instead of missed.
Our lab, start to finish
We own and operate the laboratory. No third-party specimen networks, no hand-offs, no unexplained delays.
MD-supervised, MD-operated
Directed by a board-certified Clinical Pathologist and Geneticist with 25 years of specialized diagnostic expertise.
Advocacy after the result
Confidential consultations, insurance approvals for specialty medications, and access to 340B state programs.
Detection at the DNA level, not the symptom level
The CDC notes that traditional antigen-based testing — still used by the vast majority of consumer testing vendors — can miss up to 40% of positive cases. We use Nucleic Acid Amplification Testing (PCR), the recognized clinical gold standard, which amplifies tiny fragments of bacterial and viral DNA/RNA to detect even the earliest infections with over 99% sensitivity.
The in-house advantage
Privacy, convenience, and reduced social stigma are the primary reasons young adults now prefer at-home testing. National research led by the University of Michigan and published in the Journal of Adolescent Health found that between 70% and 91% of young people favor self-collection kits over an in-person clinic visit.
Most online services are lead generators that outsource your specimen. We maintain full ownership and oversight of our laboratory infrastructure.
STD PCR vs. typical online testing services
| What matters | STD PCR | Typical competitor |
|---|---|---|
| Testing method | PCR / NAAT amplification of viral and bacterial DNA-RNA | Antigen or antibody testing that can miss early infection |
| Laboratory control | In-house laboratory we own and oversee end to end | Lead-generation model outsourcing specimens to third-party networks |
| Turnaround | Typically 24 hours from laboratory receipt, plus STAT PCR options | Advertised windows routinely exceeded due to network hand-offs |
| Panel design | Clinically relevant 15–17 test panels including viral load | Redundant tests added to inflate the panel count |
| Collection scope | Oral, rectal, urine and blood collection where clinically indicated | Blood or urine only — missing site-specific infections |
| Care after a positive | Confidential consultation included, no separate consult fee | Extra charges for consultation or prescription after a positive |
| Medication advocacy | Insurance approvals pursued and 340B program access facilitated | No insurance support — patients absorb specialty drug costs alone |
| Data handling | Isolated, privacy-first data architecture | Results potentially fed into broad commercial or insurance databases |
Our responsibility doesn't end with a result
We are an MD-supervised and MD-operated service providing end-to-end medical support — including confidential consultations and active advocacy for insurance approval of expensive specialty medications.
Marketing volume is not patient care
Hidden fees for care
Many competitors charge extra for consultations or prescriptions after a positive result, creating a financial barrier at the exact moment treatment matters most.
Limited testing scopes
Standard commercial labs often rely solely on blood or urine, missing infections that require oral or rectal collection for an accurate health profile.
No advocacy
Most competitors do not accept insurance or assist with medication approvals, leaving patients to navigate the cost of treatment on their own.
Operational delays
Third-party specimen networks routinely push turnaround past advertised windows, extending the anxiety of waiting.